Gastrointestinal Bleeding in Critically Ill Cancer Patients
Authors:
- 13 October 2019
- book chapter
- Published by Springer Nature
- p. 857-867
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2018
- Efficacy of Over-the-Scope Clips in Management of High-Risk Gastrointestinal BleedingClinical Gastroenterology and Hepatology, 2018
- Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumabAnnals of Oncology, 2017
- The role of early colonoscopy in acute lower GI bleeding: summarizing conflicting data in the presence of society recommendationsGastrointestinal Endoscopy, 2017
- Development and Validation of a Risk Scoring System for Severe Acute Lower Gastrointestinal BleedingClinical Gastroenterology and Hepatology, 2016
- Recurrence and Mortality Among Patients Hospitalized for Acute Lower Gastrointestinal BleedingClinical Gastroenterology and Hepatology, 2015
- Severe Gastrointestinal Hemorrhage During Targeted Therapy for Advanced Breast CarcinomaCurrent Oncology, 2014
- Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2014
- Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careThe Lancet Oncology, 2010
- Higher hospital volume is associated with lower mortality in acute nonvariceal upper-GI hemorrhageGastrointestinal Endoscopy, 2009